Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease

被引:32
作者
Li, W. -C. [1 ]
Lee, Y. -Y. [2 ,3 ]
Chen, I. -C. [4 ,5 ]
Wang, S. -H. [6 ,7 ,8 ,9 ]
Hsiao, C. -T. [4 ,5 ]
Loke, S. -S. [10 ]
机构
[1] Chang Gung Mem Hosp Keelung, Dept Occupat Med, Keelung 20441, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Neurol Inst, Div Pediat Neurosurg, Taipei, Taiwan
[4] Chang Gung Mem Hosp Chiayi, Dept Emergency Med, Chiayi, Taiwan
[5] Chang Gung Inst Technol, Chiayi, Taiwan
[6] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan
[7] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Taipei, Taiwan
[8] Taipei Med Univ, Coll Med, Sch Med, Dept Emergency, Taipei, Taiwan
[9] Natl Taitung Univ, Dept Phys Educ, Taitung, Taiwan
[10] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan
关键词
Chronic kidney disease; creatinine; eGFR; hepatitis C virus; proteinuria; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; VIRUS SEROPOSITIVITY; ALCOHOL-CONSUMPTION; SERUM CREATININE; PREVALENCE; ASSOCIATION; RISK; ADULTS; CKD;
D O I
10.1111/jvh.12199
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic kidney disease (CKD) is a worldwide health issue with heavy economic burden. Chronic hepatitis C virus (HCV) infection is a common cause of CKD, which can significantly impact the progression and mortality among patients with CKD. The prevalence of both illnesses is high in Taiwan. A multicentre and population-based cross-sectional study including 24642 subjects was conducted to explore the association of HCV infection with the prevalence and severity of CKD. The measurements of metabolic parameters, eGFR and CKD stages were compared between subjects with HCV seropositivity and seronegativity. The analyses of association between HCV infection with CKD stages and evaluation of potential risk factors of CKD were performed by gender and age ( and >45years). HCV-seropositive subjects accounted for 6.9% and had a significantly older age. The prevalence of CKD increased in those with HCV seropositivity (16.5%). Significantly higher prevalence of CKD stages 3 in HCV-seropositive subjects was noticed (7.8%). Age (>45year), male gender, alcohol drinking, hypertension, creatinine and HCV infection were the significant factors associated with the presence of CKD. HCV seropositivity was an independent risk factor of developing CKD and associated with an increased risk of having CKD of all stages. The higher prevalence of earlier stage of CKD warrants longitudinal studies with frequent testing on renal function and sufficient duration to determine the changes of eGFR over time. Implementation of effective treatment intervention is also required for these subjects to prevent the progression of CKD to late stages.
引用
收藏
页码:706 / 715
页数:10
相关论文
共 49 条
[1]   Metabolic alterations and chronic hepatitis C: treatment strategies [J].
Adinolfi, Luigi E. ;
Restivo, Luciano ;
Zampino, Rosa ;
Lonardo, Amedeo ;
Loria, Paola .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (14) :2215-2234
[2]   Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels [J].
Bostom, AG ;
Kronenberg, F ;
Ritz, E .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (08) :2140-2144
[3]  
Carithers Robert L. Jr., 1999, American Journal of Medicine, V107, p90S
[4]   Renal manifestations of hepatitis C infection [J].
Daghestani, L ;
Pomeroy, C .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (03) :347-354
[5]   K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].
Eknoyan, G ;
Levin, NW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266
[6]   Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis [J].
Fabrizi, F ;
Martin, P ;
Dixit, V ;
Bunnapradist, S ;
Dulai, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (11-12) :1271-1277
[7]   Hepatitis C virus and atherosclerosis in patients with type 2 diabetes [J].
Fukui, M ;
Kitagawa, Y ;
Nakamura, N ;
Yoshikawa, T .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (10) :1245-1246
[8]   Liver damage in hemodialysis patients with hepatitis C virus viremia: A prospective 10-year study [J].
Furusyo, N ;
Hayashi, J ;
Kanamoto-Tanaka, Y ;
Ariyama, I ;
Etoh, Y ;
Shigematsu, M ;
Kashiwagi, S .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (11) :2221-2228
[9]   Screening for CKD with eGFR: Doubts and dangers [J].
Glassock, Richard J. ;
Winearls, Christopher .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05) :1563-1568
[10]  
Gluhovschi Gh, 2012, Rom J Intern Med, V50, P135